These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24818590)

  • 1. Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial.
    Gomaa MF; Elkholy AG; El-Said MM; Abdel-Salam NE
    Arch Gynecol Obstet; 2014 Oct; 290(4):757-62. PubMed ID: 24818590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
    Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
    Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of peripheral blood NK cell subsets and cytokines in unexplained recurrent miscarriage.
    Adib Rad H; Basirat Z; Mostafazadeh A; Faramarzi M; Bijani A; Nouri HR; Soleimani Amiri S
    J Chin Med Assoc; 2018 Dec; 81(12):1065-1070. PubMed ID: 30145058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium.
    Tang AW; Alfirevic Z; Turner MA; Drury J; Quenby S
    Trials; 2009 Nov; 10():102. PubMed ID: 19903335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of heparin combined with aspirin versus aspirin alone for unexplained recurrent spontaneous abortion.
    Li J; Gao YH; Xu L; Li ZY
    Int J Gynaecol Obstet; 2020 Oct; 151(1):23-32. PubMed ID: 32535924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
    Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S
    N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
    Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ
    Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
    Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
    Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.
    Empson M; Lassere M; Craig J; Scott J
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002859. PubMed ID: 15846641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial.
    Pasquier E; de Saint Martin L; Bohec C; Chauleur C; Bretelle F; Marhic G; Le Gal G; Debarge V; Lecomte F; Denoual-Ziad C; Lejeune-Saada V; Douvier S; Heisert M; Mottier D
    Blood; 2015 Apr; 125(14):2200-5. PubMed ID: 25636341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study.
    Fawzy M; Shokeir T; El-Tatongy M; Warda O; El-Refaiey AA; Mosbah A
    Arch Gynecol Obstet; 2008 Jul; 278(1):33-8. PubMed ID: 18071727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial.
    Ismail AM; Abbas AM; Ali MK; Amin AF
    J Matern Fetal Neonatal Med; 2018 Feb; 31(3):388-394. PubMed ID: 28114846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy.
    Cohn DM; Goddijn M; Middeldorp S; Korevaar JC; Dawood F; Farquharson RG
    J Thromb Haemost; 2010 Oct; 8(10):2208-13. PubMed ID: 20704646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of prophylactic use of low dose aspirin and calheparin in patients with unexplained recurrent abortion.
    Maged AM; Abdelhafiz A; Mostafa WA; El-Nassery N; Fouad M; Salah E; Kotb A
    Gynecol Endocrinol; 2016 Dec; 32(12):970-972. PubMed ID: 27426855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
    Elmahashi MO; Elbareg AM; Essadi FM; Ashur BM; Adam I
    BMC Res Notes; 2014 Jan; 7():23. PubMed ID: 24405979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.